An analytical method for the identification of cell type-specific disease gene modules
Tóm tắt
Genome-wide association studies have identified genetic variants associated with the risk of brain-related diseases, such as neurological and psychiatric disorders, while the causal variants and the specific vulnerable cell types are often needed to be studied. Many disease-associated genes are expressed in multiple cell types of human brains, while the pathologic variants affect primarily specific cell types. We hypothesize a model in which what determines the manifestation of a disease in a cell type is the presence of disease module comprised of disease-associated genes, instead of individual genes. Therefore, it is essential to identify the presence/absence of disease gene modules in cells. To characterize the cell type-specificity of brain-related diseases, we construct human brain cell type-specific gene interaction networks integrating human brain nucleus gene expression data with a referenced tissue-specific gene interaction network. Then from the cell type-specific gene interaction networks, we identify significant cell type-specific disease gene modules by performing statistical tests. Between neurons and glia cells, the constructed cell type-specific gene networks and their gene functions are distinct. Then we identify cell type-specific disease gene modules associated with autism spectrum disorder and find that different gene modules are formed and distinct gene functions may be dysregulated in different cells. We also study the similarity and dissimilarity in cell type-specific disease gene modules among autism spectrum disorder, schizophrenia and bipolar disorder. The functions of neurons-specific disease gene modules are associated with synapse for all three diseases, while those in glia cells are different. To facilitate the use of our method, we develop an R package, CtsDGM, for the identification of cell type-specific disease gene modules. The results support our hypothesis that a disease manifests itself in a cell type through forming a statistically significant disease gene module. The identification of cell type-specific disease gene modules can promote the development of more targeted biomarkers and treatments for the disease. Our method can be applied for depicting the cell type heterogeneity of a given disease, and also for studying the similarity and dissimilarity between different disorders, providing new insights into the molecular mechanisms underlying the pathogenesis and progression of diseases.
Tài liệu tham khảo
Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 2015;47(6):569.
Huang JK, Carlin DE, Yu MK, Zhang W, Kreisberg JF, Tamayo P, et al. Systematic evaluation of molecular networks for discovery of disease genes. Cell Syst. 2018;6(4):484–95.
Sonawane AR, Platig J, Fagny M, Chen C-Y, Paulson JN, Lopes-Ramos CM, et al. Understanding tissue-specific gene regulation. Cell Rep. 2017;21(4):1077–88.
Barshir R, Shwartz O, Smoly IY, Yeger-Lotem E. Comparative analysis of human tissue interactomes reveals factors leading to tissue-specific manifestation of hereditary diseases. PLoS Comput Biol. 2014;10(6):e1003632.
Feiglin A, Allen BK, Kohane IS, Kong SW. Comprehensive analysis of tissue-wide gene expression and phenotype data reveals tissues affected in rare genetic disorders. Cell Syst. 2017;5(2):140–82.
Marbach D, Lamparter D, Quon G, Kellis M, Kutalik Z, Bergmann S. Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods. 2016;13(4):366–70.
Kitsak M, Sharma A, Menche J, Guney E, Ghiassian SD, Loscalzo J, et al. Tissue specificity of human disease module. Sci Rep. 2016;6(1):35241.
Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, et al. Brain cell type–specific enhancer–promoter interactome maps and disease < strong > -</strong > risk association. Science. 2019;366(6469):1134–9.
Schirmer L, Velmeshev D, Holmqvist S, Kaufmann M, Werneburg S, Jung D, et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature. 2019;573(7772):75–82.
Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron. 2011;71(1):35–48.
Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M, et al. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci. 2019;22(1):47–56.
Reynolds RH, Botía J, Nalls MA, Noyce AJ, Nicolas A, Cookson MR, et al. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. NPJ Parkinson’s Dis. 2019;5(1):6.
Skene NG, Grant SG. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front Neurosci. 2016;10:16.
Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, et al. Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019;573(7772):61-68.
McCarthy DJ, Campbell KR, Lun ATL, Wills QF. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics. 2017;33(8):1179–86.
Lun ATL, McCarthy DJ, Marioni JC. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Research. 2016;5:2122.
Calvo SE, Clauser KR, Mootha VK. MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 2016;44(D1):D1251–D7.
Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40.
McKenzie AT, Wang M, Hauberg ME, Fullard JF, Kozlenkov A, Keenan A, et al. Brain cell type specific gene expression and co-expression network architectures. Sci Rep. 2018;8(1):8868.
Wu Y, Yao Y-G, Luo X-J. SZDB: a database for schizophrenia genetic research. Schizophr Bull. 2017;43(2):459–71.
Chang S-H, Gao L, Li Z, Zhang W-N, Du Y, Wang J. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder. Biol Psychiat. 2013;74(10):727–33.
Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57(1):289–300.
Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.
Ebrahimi-Fakhari D, Sahin M. Autism and the synapse: Emerging mechanisms and mechanism-based therapies. Curr Opin Neurol. 2015;28(2):91–102.
Sobue A, Kushima I, Nagai T, Shan W, Kohno T, Aleksic B, et al. Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia. Sci Rep. 2018;8(1):13046.
Wang P, Zhao D, Lachman HM, Zheng D. Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons. Transl Psychiatry. 2018;8(1):13.
Zhang Q, Huang Y, Zhang L, Ding Y-Q, Song N-N. Loss of Satb2 in the Cortex and Hippocampus Leads to Abnormal Behaviors in Mice. Frontiers in Molecular Neuroscience. 2019;12(33).
Lammert DB, Howell BW. RELN Mutations in autism spectrum disorder. Front Cell Neurosci. 2016;10:84.
Lammert DB, Middleton FA, Pan J, Olson EC, Howell BW. The de novo autism spectrum disorder RELN R2290C mutation reduces Reelin secretion and increases protein disulfide isomerase expression. J Neurochem. 2017;142(1):89–102.
Hill SA, Blaeser AS, Coley AA, Xie Y, Shepard KA, Harwell CC, et al. Sonic hedgehog signaling in astrocytes mediates cell type-specific synaptic organization. Elife. 2019;8:e45545.
Chung W-S, Allen NJ, Eroglu C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harbor Persp Biol. 2015;7(9):a020370.
Dyer LA, Patterson C. Development of the endothelium: an emphasis on heterogeneity. Semin Thromb Hemost. 2010;36(3):227–35.
Tirziu D, Simons M. Endothelium as master regulator of organ development and growth. Vascul Pharmacol. 2009;50(1–2):1–7.
Csardi G, Nepusz T. The igraph software package for complex network research. J Complex Syst. 2006;1695(5):1–9.
Skaar D, Shao Y, Haines J, Stenger J, Jaworski J, Martin ER, et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry. 2005;10(6):563–71.
Ovadia G, Shifman S. The genetic variation of RELN expression in schizophrenia and bipolar disorder. PloS ONE. 2011;6(5):e19955.
Ishii T, Ishikawa M, Fujimori K, Maeda T, Kushima I, Arioka Y, et al. <em> In Vitro </em> Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of <em> PCDH1 </em> 5 and <em> RELN </em>. Eneuro. 2019;6(5):ENEURO.0403-18.2019.
Kryuchkova-Mostacci N, Robinson-Rechavi M. A benchmark of gene expression tissue-specificity metrics. Brief Bioinform. 2017;18(2):205–14.